Operator of a contract development and manufacturing company designed to specialise in plant-based expression and production of proteins, vaccines and complex natural products. The company uses Hypertrans®, the proprietary transient expression technology that allows for the rapid simultaneous production of multiple gene products in a controlled and coordinated manner within the tissues of plants, enabling clients to rapidly respond to emergencies like pandemics.